Skip to main content
ArticleOPEN ACCESS

CXCL13 is a biomarker of anti-leucine-rich glioma-inactivated protein 1 encephalitis patients [response to letter]

Neuropsychiatric Disease and Treatment
DOI: 10.2147/NDT.S246085
0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Wang, S. J., & Liu, X. W. (2020). CXCL13 is a biomarker of anti-leucine-rich glioma-inactivated protein 1 encephalitis patients [response to letter]. Neuropsychiatric Disease and Treatment. Dove Medical Press Ltd. https://doi.org/10.2147/NDT.S246085

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free